Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world's largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the “fiscal cliff” bill that did not mention the company by name but strongly favored one of its drugs.
Big Senate gift to drugmaker Amgen
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.